David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Seaboard Corp
SEB
$3.96B
| $3.48M | ﹤0.01% |
877
+8
| +0.9% | +$32.3K |
|
1752
MasterCraft Boat Holdings
MCFT
$599M
| $3.47M | ﹤0.01% |
119,941
+11,709
| +11% | +$324K |
|
1753
PUT
Royal Gold
RGLD
$22.7B
| $3.47M | ﹤0.01% |
37,400
+2,000
| +6% | +$179K |
|
|
THR
1754
DELISTED
Thermon Group Holdings
THR
| $3.47M | ﹤0.01% |
151,787
+191
| +0.1% | +$4.47K |
|
1755
Graham Holdings Company
GHC
$4.99B
| $3.47M | ﹤0.01% |
5,915
-151
| -2% | -$90.6K |
|
1756
H&R Block
HRB
$6.56B
| $3.46M | ﹤0.01% |
152,099
+71,648
| +89% | +$1.9M |
|
|
VAR
1757
DELISTED
Varian Medical Systems, Inc.
VAR
| $3.46M | ﹤0.01% |
+30,473
| New | +$3.65M |
|
|
CAVM
1758
CALL
DELISTED
Cavium, Inc.
CAVM
| $3.46M | ﹤0.01% |
40,000
| – | – |
|
|
WCN
1759
Waste Connections
WCN
$41.8B
| $3.45M | ﹤0.01% |
45,849
+9,893
| +28% | +$740K |
|
1760
CALL
HubSpot
HUBS
$11.9B
| $3.45M | ﹤0.01% |
27,500
+22,000
| +400% | +$2.61M |
|
1761
United Parcel Service
UPS
$89.5B
| $3.45M | ﹤0.01% |
32,435
-261,778
| -89% | -$29.4M |
|
|
UFS
1762
DELISTED
DOMTAR CORPORATION (New)
UFS
| $3.45M | ﹤0.01% |
72,197
+65,546
| +986% | +$3.04M |
|
|
Y
1763
DELISTED
Alleghany Corp
Y
| $3.44M | ﹤0.01% |
5,983
+136
| +2% | +$79.4K |
|
1764
PUT
Cardinal Health
CAH
$55.3B
| $3.44M | ﹤0.01% |
70,400
+3,400
| +5% | +$193K |
|
1765
Arbutus Biopharma
ABUS
$1.03B
| $3.44M | ﹤0.01% |
470,508
-239,954
| -34% | -$1.43M |
|
1766
CALL
Qualys
QLYS
$6.09B
| $3.43M | ﹤0.01% |
+40,700
| New | +$3.27M |
|
1767
KB Home
KBH
$3.5B
| $3.43M | ﹤0.01% |
125,832
-19,086
| -13% | -$513K |
|
|
OTIC
1768
DELISTED
Otonomy, Inc.
OTIC
| $3.4M | ﹤0.01% |
884,026
+66,818
| +8% | +$278K |
|
1769
Entravision Communication
EVC
$752M
| $3.4M | ﹤0.01% |
679,934
+68,643
| +11% | +$316K |
|
1770
Cameco
CCJ
$46.6B
| $3.4M | ﹤0.01% |
301,802
+149,288
| +98% | +$1.63M |
|
1771
TG Therapeutics
TGTX
$8.48B
| $3.39M | ﹤0.01% |
257,574
+62,050
| +32% | +$853K |
|
1772
Halozyme
HALO
$12.4B
| $3.39M | ﹤0.01% |
200,738
+129,054
| +180% | +$2.44M |
|
|
INWK
1773
DELISTED
InnerWorkings, Inc.
INWK
| $3.38M | ﹤0.01% |
389,248
+35,585
| +10% | +$328K |
|
|
VER
1774
DELISTED
VEREIT, Inc.
VER
| $3.38M | ﹤0.01% |
90,709
-2,169
| -2% | -$76.1K |
|
1775
PUT
ConocoPhillips
COP
$158B
| $3.37M | ﹤0.01% |
+48,400
| New | +$3.22M |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.